A Case of Adenocarcinoma of the Small Intestine in a Japanese Patient with Crohn Disease: A Report with Immunohistochemical and Oncogenic Analyses

References

• Moesgaard F, Knudsen JT, Christensen N. Adenocarcinoma of the small intestine associated with Crohn’s disease. Acta Chir Scand 1979;145:577–80.
   Google Scholar
• Heathcote J, Knauer CM, Oakes D, Archibald RWR. Perforation of an adenocarcinoma of the small bowel affected by regional enteritis. Gut 1980;21:1093–6.
   PubMedGoogle Scholar
• Fresko D, Lazarus SS, Dotan J, Reingold M. Early presentation of carcinoma of the small bowel in Crohn’s disease (‘Crohn’s carcinoma’). Gastroenterology 1982;82:783–9.
   PubMedGoogle Scholar
• Adler SN, Lyon DT, Sullivan PD. Adenocarcinoma of the small bowel: clinical features, similarity to regional enteritis, and analysis of 338 documented cases. Am J Gastroenterol 1982;77: 326–30.
   Google Scholar
• Johnson AM, Harman PK, Hanks JB. Primary small bowel malignancies. Am Surg 1985;51:31–6.
   Google Scholar
• Ouriel K, Adams JT. Adenocarcinoma of the small intestine. Am J Surgery 1984;147:66–71.
   PubMed Web of Science ®Google Scholar
• Savoca PE, Ballantyne GH, Cahow CE. Gastrointestinal malignancies in Crohn’s disease: a 20-year experience. Dis Colon Rectum 1990;33: 7–11.
   Google Scholar
• Ribeiro MB, Greenstein AJ, Heimann TM, Yamazaki Y, Aufses AH Jr. Adenocarcinoma of the small intestine in Crohn’s disease. Surgery 1991;173:343–9.
   Google Scholar
• Lashner BA. Risk factors for small bowel cancer in Crohn’s disease. Dig Dis Sci 1992;37:1179–84.
   PubMed Web of Science ®Google Scholar
• Michelassi F, Testa G, Pomidor WJ, Lashner BA, Block GE. Adenocarcinoma complicating Crohn’s disease. Dis Colon Rectum 1993;36:654–61.
   PubMedGoogle Scholar
• Rashid A, Hamilton SR. Genetic alterations in sporadic and Crohn’s-associated adenocarcinomas of the small intestine. Gastroenterology 1997;113:127–35.
   PubMed Web of Science ®Google Scholar
• Frank JD, Shorey BA. Adenocarcinoma of the small bowel as a complication of Crohn’s disease. Gut 1973;14:120–4.
   PubMedGoogle Scholar
• Watanabe M, Nakano H, Takano E, Miyachi I, Ito M, Kawase K. A case of small bowel carcinoma in Crohn disease. Gastroenterol Jpn 1991;26:514–22.
   PubMedGoogle Scholar
• Fearon ER, Cho KR, Nigro JM, Kern SE, Simons JW, Ruppert JM, et al. Identification of a chromosome 18q gene that is altered in colorectal cancers. Science 1990;247:49–56.
   PubMed Web of Science ®Google Scholar
• Greenwald BD, Harpaz N, Yin J, Huang Y, Tong Y, Brown VL, et al. Loss of heterozygosity affecting the p53, Rb, and mcc/apc tumor suppressor gene loci in dysplastic and cancerous ulcerative colitis. Cancer Res 1992;52:741–5.
   Google Scholar
• Brentnall TA, Crispin DA, Rabinovitch PS, Haggitt RC, Rubin CE, Stevens AC, et al. Mutation in the p53 gene: an early marker of neoplastic progression in ulcerative colitis. Gastroenterology 1994;107:369–78.
   PubMed Web of Science ®Google Scholar
• Burmer Gc, Levine DS, Kulander BG, Haggitt RC, Rubin CE, Rabinovitch PS. C-Ki-ras mutations in chronic ulcerative colitis and sporadic colon carcinoma. Gastroenterology 1990;99: 416–20.
   Google Scholar
• Redston MS, Papadopoulos N, Caldas C, Kinzler KW, Kern SE. Common occurrence of APC and K-ras gene mutations in the spectrum of colitis-associated neoplasias. Gastroenterol 1995; 108:383–92.
   Google Scholar
• El-Deiry WS, Harper JW, O’Connor PM, Velculescu VE, Canman CE, Jackman J, et al. WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res 1994;54: 1169–74.
   Google Scholar
• Wang Y, Szekely L, Okan I, Klein G, Wiman KG. Wild-type p53-triggered apoptosis is inhibited by bcl-2 in a v-myc-induced T-cell lymphoma line. Oncogene 1993;8: 3427–31.
   Google Scholar
• Sinicrope FA, Ruan SIB, Cleary KR, Stephens LC, Lee JJ, Levin B. bcl-2 and p53 oncoprotein expression during colorectal tumorigenesis. Cancer Res 1995;55:237–41.
   PubMed Web of Science ®Google Scholar
• Doglioni C, Pelosio P, Laurino L, Macri E, Meggiolaro E, Favretti F, et al. p21/WAF1/CIP1 expression in normal mucosa and in adenomas and adenocarcinomas of the colon: its relationship with differentiation. J Pathol 1996;179:248–53.
   PubMed Web of Science ®Google Scholar
• Krajewska M, Moss SF, Krajewski S, Song K, Holt PR, Reed JC. Elevated expression of Bcl-X and reduced Bak in primary colorectal adenocarcinomas. Cancer Res 1996;56:2422–7.
   PubMed Web of Science ®Google Scholar
• Miura M, Hiwatashi N, Yamashita K, Kimura M. Immunohistologic characterization of epitheloid cells in Crohn’s granulomas. J Clin Lab Immunol 1989;28:11–4.
   PubMedGoogle Scholar
• Yao K, Iwashita A, Yao T, Takemura S, Furukawa K, Matsui T, et al. Increased numbers of macrophages in noninflamed gastroduodenal mucosa of patients with Crohn’s disease. Dig Dis Sci 1996;41:2260–7.
   PubMedGoogle Scholar
• Kerr JFR, Gobé GC, Winterford CM, Harmon BV. Anatomical methods in cell death. Methods Cell Biol 1995;46:1–27.
   PubMed Web of Science ®Google Scholar
• Yamashita K, Tatebayashi T, Shinoda H, Okayasu I. Simplified rapid non-radioactive PCR-SSCP method applied to K-ras mutation analysis. Pathol Int 1996;146:801–4.
   Google Scholar
• Krishna M, Woda B, Savas L, Baker S, Banner B. Expression of p53 antigen in inflamed and regenerated mucosa in ulcerative colitis and Crohn’s disease. Modern Pathol 1995;8: 654–7.
   Google Scholar
• Arai N, Mitomi H, Ohtani Y, Igarashi M, Kakita A, Okayasu I. Enhanced epithelial cell turnover associated with p53 accumulation and high p21WAF1/CIP1 expression in ulcerative colitis. Mod Pathol 1999;12:604–11.
   PubMed Web of Science ®Google Scholar
• Oltvai ZN, Milliman CL, Korsmeyer W. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programed cell death. Cell 1993;74: 609–19.
   Google Scholar